英文名称 |
中文名称 |
CAS号 |
操作 |
TAE684 |
NVP-TAE684 |
761439-42-3 |
详细
|
CYC-116 |
CYC-116 |
693228-63-6 |
详细
|
N-(3-Chlorophenyl)-N'-[5-[2-(thieno[3,2-d]pyrimidin-4-ylamino)ethyl]-2-thiazolyl]urea |
N-(3-氯苯基)-N'-[5-[2-(噻吩并[3,2-D]嘧啶-4-基氨基)乙基]-2-噻唑基]脲 |
1057249-41-8 |
详细
|
Nintedanib esylate |
尼达尼布乙磺酸盐 |
656247-18-6 |
详细
|
CGP60474 |
3-[[4-[2-[(3-氯苯基)氨基]-4-嘧啶基]-2-吡啶基]氨基]-1-丙醇 |
164658-13-3 |
详细
|
LY2835219 |
LY2835219 |
1231930-82-7 |
详细
|
AA41612 |
化合物AA41612 |
433690-62-1 |
详细
|
FITM |
4-氟-N-[4-[6-(异丙基氨基)嘧啶-4-基]-1,3-噻唑-2-基]-N-甲基苯甲酰胺 |
932737-65-0 |
详细
|
CP 94253 dihydrochloride |
CP 94253盐酸盐 |
845861-39-4 |
详细
|
NI-57 |
NI-57 |
1883548-89-7 |
详细
|
Dovitinib |
4-氨基-5-氟-3-[5-(4-甲基哌嗪-1-基)-1H-苯并咪唑-2-基]喹啉-2(1H)-酮 |
405169-16-6 |
详细
|
Indibulin |
2-(1-(4-氯苄基)-1H-吲哚-3-基)-2-氧代-N-(吡啶-4-基)乙酰胺 |
204205-90-3 |
详细
|
Ibrutinib |
依鲁替尼 Ibrutinib(PCI-32765) |
936563-96-1 |
详细
|
Carfilzomib |
卡非佐米 |
868540-17-4 |
详细
|
Varlitinib |
泛EGFR小分子抑制剂(VARLITINIB) |
845272-21-1 |
详细
|
LDC000067 |
(3-(6-(2-甲氧基苯基)嘧啶-4-基氨基)苯基)甲烷磺酰胺 |
1073485-20-7 |
详细
|
BMS 986187 |
BMS 986187 |
684238-37-7 |
详细
|
3,5-Bis[(4-nitrophenyl)methylene]-2,3,5,6-tetrahydro-4H-thiopyran-4-one-1,1-dioxide;3,5-bis((4-Nitrophenyl)methylene)-1,1-dioxide;tetrahydro-4H-thiopyran-4-one;NSC-144303;Ubiquitin Isopeptidase Inhibitor I;tetrahydro-3,5-bis[(4-nitrophenyl)methylene]-4H-t |
108477-18-5 |
108477-18-5 |
详细
|
Src Inhibitor-1 |
7-二甲氧基-N-(4-苯氧基苯基)- 氨基喹唑啉 |
179248-59-0 |
详细
|
GSK 2018682 |
CPD1224 |
1034688-30-6 |
详细
|
Sapitinib |
AZD8931 |
848942-61-0 |
详细
|
Necrosulfonamide |
N-[4-[[(3-甲氧基吡嗪基)氨基]磺酰基]苯基]-3-(5-硝基-2-噻吩基)-2-丙烯酰胺 |
432531-71-0 |
详细
|
Afatinib dimaleate |
双马来酸盐阿法替尼 |
850140-73-7 |
详细
|
K-Ras(G12C) inhibitor 12 |
K-RAS(G12C) INHIBITOR 12 |
1469337-95-8 |
详细
|
Pexidartinib |
培西达替尼 |
1029044-16-3 |
详细
|
ML 179 |
ML-179 |
1883548-87-5 |
详细
|
2-undecyl-thiazolidine-4-carboxylic acid |
2-UNDECYL-THIAZOLIDINE-4-CARBOXYLIC ACID |
298186-80-8 |
详细
|
MYCi361 |
MYCI361 |
2289690-31-7 |
详细
|
TSU-68 |
orantinib |
252916-29-3 |
详细
|
RS 67333 hydrochloride |
RS 67333盐酸盐 |
168986-60-5 |
详细
|
Trametinib |
曲美替尼 |
871700-17-3 |
详细
|
Fostamatinib Disodium |
R788(FOSTAMATINIB DISODIUM) |
1025687-58-4 |
详细
|
BIBO3304 TFA |
N-[(1R)-1-[[[[4-[[(Aminocarbonyl)amino]methyl]phenyl]methyl]amino]carbonyl]-4-[(aminoiminomethyl)amino]butyl]-α-phenyl-benzeneacetamideditrifluoroacetate |
191868-14-1 |
详细
|
EGFR inhibitor |
EGFR INHIBITOR |
879127-07-8 |
详细
|
BMS-265246 |
BMS265246 |
582315-72-8 |
详细
|
Osilodrostat |
LCI 699 |
928134-65-0 |
详细
|
MG-132 |
MG132,蛋白酶体抑制剂 |
133407-82-6 |
详细
|
TCS-OX2-29 |
TCS-OX2-29 HCl |
1610882-30-8 |
详细
|
PF 05190457 |
PF-05190457, CID 58438464 |
1334782-79-4 |
详细
|
CGS 15943 |
CGS 15943 |
104615-18-1 |
详细
|
Selpercatinib |
塞卡替尼 |
2152628-33-4 |
详细
|
Lopinavir |
洛匹那韦 |
192725-17-0 |
详细
|
Cediranib |
西地尼布 |
288383-20-0 |
详细
|
Telaprevir |
特拉匹韦(VX-950) |
402957-28-2 |
详细
|
Aurora kinase inhibitor-3 |
AURORA KINASE INHIBITOR III |
879127-16-9 |
详细
|
Motolimod |
MOTOLIMOD |
926927-61-9 |
详细
|
GC376 |
GC376 |
1416992-39-6 |
详细
|
CAY10404 |
3-(4-METHYLSULPHONYLPHENYL)-4-PHENYL-5-TRIFLUOROMETHYLISOXAZOLE |
340267-36-9 |
详细
|
OSI-420 |
2-[[4-[(3-乙炔基苯基)氨基]-7-(2-甲氧基乙氧基)-6-喹唑啉基]氧基]乙醇 |
183321-86-0 |
详细
|
Trandolaprilat |
群多普利 |
87679-71-8 |
详细
|
Linifanib |
利尼伐尼 |
796967-16-3 |
详细
|
Thiamet G |
THIAMET G |
1009816-48-1 |
详细
|
R788 |
福他替尼 |
901119-35-5 |
详细
|
TCS 1102 |
TCS 1102 |
916141-36-1 |
详细
|
4-[4-[[[[4-Chloro-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]-3-fluorophenoxy]-N-methyl-2-pyridinecarboxamide hydrate |
瑞格非尼一水合物 |
1019206-88-2 |
详细
|
Dovitinib (TKI-258) Dilactic Acid |
多韦替尼二乳酸 |
852433-84-2 |
详细
|
K-115 |
(2S)-1-[(4-氟-5-异喹啉基)磺酰基]六氢-2-甲基-1H-1,4-二氮杂卓单盐酸盐二水合物 |
887375-67-9 |
详细
|
GNE-0877 |
GNE-0877 |
1374828-69-9 |
详细
|
Pemigatinib |
培米加替尼 |
1513857-77-6 |
详细
|
BVT 948 |
4-羟基-3,3-二甲基-2H-苯并[G]吲哚-2,5(3H)-二酮 |
39674-97-0 |
详细
|
Raltegravir |
雷特格韦 |
518048-05-0 |
详细
|
AH 6809 |
6-异丙氧基-9-氧代氧杂蒽-2-羧酸 |
33458-93-4 |
详细
|
GSK461364 |
GSK461364 |
929095-18-1 |
详细
|
Alectinib |
艾乐替尼 |
1256580-46-7 |
详细
|
MK-5108 (VX-689) |
MK-5108 (VX-689) |
1010085-13-8 |
详细
|
ASP-3026 |
ASP3026 |
1097917-15-1 |
详细
|
PRX 07034 |
5-氯-2,3-二甲氧基-Α-甲基-N-[2-(甲基磺酰基)-5-(1-哌嗪基)苯基]-苯甲胺盐酸盐 |
903580-39-2 |
详细
|
GSK-J4 |
N-[2-(2-吡啶基)-6-(1,2,4,5-四氢-3H-3-苯并氮杂卓-3-基)-4-嘧啶基]-BETA-丙氨酸乙酯 |
1373423-53-0 |
详细
|
CYM 5520 |
1-[2-(1-Benzyl-2,5-dimethyl-1H-pyrrol-3-yl)-2-oxo-ethyl]-6-oxo-1,6-dihydro-pyridine-3-carbonitrile |
1449747-00-5 |
详细
|
Derazantinib |
德拉赞替尼 |
1234356-69-4 |
详细
|
Favipiravir |
法匹拉韦 |
259793-96-9 |
详细
|
Ki8751 |
Ki8751 |
228559-41-9 |
详细
|
PF-562271 |
N-甲基-N-[3-[[[2-[(2-氧代-2,3-二氢-1H-吲哚-5-基)氨基]-5-三氟甲基嘧啶-4-基]氨基]甲基]吡啶-2-基]甲磺酰胺 |
717907-75-0 |
详细
|
Nintedanib |
尼达尼布 |
656247-17-5 |
详细
|
Rhosin hydrochloride |
1281870-42-5 |
1281870-42-5 |
详细
|
SHA 68 |
SHA 68 |
847553-89-3 |
详细
|
PHCCC |
N-苯基-7-(羟基亚胺基)环丙烯并[B]苯并吡喃-1A-甲酰胺 |
179068-02-1 |
详细
|
Tropifexor |
Tropifexor |
1383816-29-2 |
详细
|
Flavopiridol |
2-(2-氯苯基)-5,7-二羟基-8-[(3S,4R)-3-羟基-1-甲基-4-哌啶基]苯并吡喃-4-酮 |
146426-40-6 |
详细
|
UC2288 |
1394011-91-6 |
1394011-91-6 |
详细
|
GSK-3 Inhibitor XIII |
(5-METHYL-1H-PYRAZOL-3-YL)-(2-PHENYLQUINAZOLIN-4-YL)AMINE |
404828-08-6 |
详细
|
LE 135 |
LE 135 |
155877-83-1 |
详细
|
EC-23 |
4-[2-(5,6,7,8-Tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)ethynyl)-benzoicacid |
104561-41-3 |
详细
|
AMG 900 |
AMG 900 |
945595-80-2 |
详细
|
CUDA |
CUDA |
479413-68-8 |
详细
|
Osimertinib mesylate |
AZD9291(甲磺酸盐) |
1421373-66-1 |
详细
|
Gilteritinib |
吉列替尼 |
1254053-43-4 |
详细
|
MPP dihydrochloride |
MPP 二盐酸盐 |
911295-24-4 |
详细
|
ZM-447439 |
ZM 447439 |
331771-20-1 |
详细
|
L-371257 |
L371,257 |
162042-44-6 |
详细
|
DCPIB |
DCPIB |
82749-70-0 |
详细
|
KU57788(NU7441) |
8-(4-二苯并噻吩基)-2-(4-吗啉基)-4H-1-苯并吡喃-4-酮 |
503468-95-9 |
详细
|
Sorafenib |
索拉非尼 |
284461-73-0 |
详细
|
AZD-4547 |
AZD-4547 |
1035270-39-3 |
详细
|
Letermovir |
莱特莫韦 |
917389-32-3 |
详细
|
LY2801653 |
梅沙替尼 |
1206799-15-6 |
详细
|
(±)-Marinopyrrole A |
(±)-MARINOPYRROLE A |
1227962-62-0 |
详细
|
CCT196969 |
CB93134226 |
1163719-56-9 |
详细
|
LYN-1604 |
蓝木定制的新产品 |
2088939-99-3 |
详细
|
GsMTx4 TFA |
GSMTX4 TFA |
|
详细
|